⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Menopause Hormone Therapy
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-21 — Estrogen Receptor-Mediated Effects of a Phytoestrogen-Rich Soy-Based Diet on Metabolic Health Following Ovariectomy in Aged Mice.: cross-connection with dietary-polyphenols: [animal-model] ERα-dependent metabolic effects of a phytoestrogen-rich soy diet in aged ovariectomized mice connect dietary polyphenols with estrogen-signaling questions relevant to menopause, without establishing equivalence to hormone therapy. (novelty: 3)
- 2026-07-20 — Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women: cross-connection with glp1-agonists: Postmenopausal obesity is a shared target population; a GLP-1 trial with geroscience endpoints in this group opens comparison with hormone-therapy approaches to postmenopausal vascular and functional aging. (novelty: 3)
- 2026-08-13 — Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried: Huberman Lab Essentials with Dr. Sara Gottfried (podcast, no new data): frames perimenopausal MHT as supporting cerebral energy metabolism when brain hypometabolism, vasomotor symptoms, and cardiometabolic risk signals appear. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Anti-aging doctor says hormone type and combination matter in menopause treatment
06-oct-2026
novelty 2
per-area 2
mentions
Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried
13-aug-2026
novelty 3
per-area 3
strengthens